Publications by authors named "Rachel Perret"

Claim this Profile
J
Jurkat T-cell lines exhibit marked genomic instability affecting karyotype, mutational profile, gene expression, immunophenotype and function.
Andrew Wilson, Nathaniel Dasyam, Felix O'Hagan, Dianna Farrell, Claire Turner, Rachel Perret

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning CAR T-cell therapies for efficacy and reduced toxicity.
Danielle Blud, Patricia Rubio-Reyes, Rachel Perret, Robert Weinkove

Semin Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity.
Jihoon William Lee, Emily Y Chen, Taylor Hu, Rachel Perret, Mary E Chaffee

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An In Vitro Model to Assess CRS Potential of CAR T Cells Using a Tumor Cell Line and Autologous Monocytes.
Yasmin Nouri, Robert Weinkove, Rachel Perret

Curr Protoc· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells.
Yasmin Nouri, Robert Weinkove, Rachel Perret

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.
Stéphanie Corgnac, Rachel Perret, Lianjun Zhang, Jean-Pierre Mach, Pedro Romero

J Immunother Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.
Rachel Perret, Sophie R Sierro, Natalia K Botelho, Stéphanie Corgnac, Alena Donda

Cancer Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
Stéphanie Corgnac, Rachel Perret, Laurent Derré, Lianjun Zhang, Kathrin Stirnemann

Cancer Immunol Immunother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.
Jan C Dudda, Bruno Salaun, Yun Ji, Douglas C Palmer, Gwennaelle C Monnot, Rachel Perret

Immunity· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inefficient boosting of antitumor CD8(+) T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions.
Joel Zhi-Iong Ma, Jianping Yang, Jim S Qin, Antonia Richter, Rachel Perret

Oncoimmunology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.
Nathaly Castro-Díaz, Bruno Salaun, Rachel Perret, Sophie Sierro, Jackeline F Romero

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity.
Sophie R Sierro, Alena Donda, Rachel Perret, Philippe Guillaume, Hideo Yagita

Eur J Immunol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo.
Kate A Andrew, Helen M A Simkins, Sabine Witzel, Rachel Perret, Jenny Hudson

J Immunol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.
Matthew Peacey, Sarah Wilson, Rachel Perret, Franca Ronchese, Vernon K Ward

Vaccine· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo.
Rachel Perret, Franca Ronchese

Eur J Immunol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector lymphoid tissue and its crucial role in protective immunity.
Nicholas van Panhuys, Rachel Perret, Melanie Prout, Franca Ronchese, Graham Le Gros

Trends Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis